Fredrick D. Ashbury
Founder at Viviphi Ltd.
Profile
Fredrick D.
Ashbury is Senior Vice President of Research for Bridgesite Clinical Research, Inc. Previously, he held senior positions in research and program evaluation at PAE Research, Inc., the Workers' Compensation Board of Ontario, the National Cancer Institute of Canada, and OpTx Corp.
Dr. Ashbury worked at McGill University and the University of Toronto.
He was a Faculty Member at the University of Manitoba, Centre for Health Studies, and York University and Associate of the Centre for Health Promotion and the University of Toronto.
Dr. Ashbury received a BA degree with honors from the University of Toronto in 1983, an MA degree from Queens University in Sociology in 1986, and a PhD from The University of York in Sociology in 1991.
Fredrick D. Ashbury active positions
| Companies | Position | Start |
|---|---|---|
Viviphi Ltd.
 Viviphi Ltd. Packaged SoftwareTechnology Services Viviphi Ltd., also known as VieCure, is an artificial intelligence platform that has developed a proprietary informatics software platform in conjunction with a clinical inference engine and point-of-care decision support system in oncology. The company is based in Denver, CO. The platform combines the latest in clinical knowledge with patient data to assist clinicians in generating personalized treatment plans and better managing a patient’s treatment throughout diagnosis, cancer therapy, and ongoing follow-up care. The company was founded by Fredrick D. Ashbury, Gerald Hogue. Gerald Hogue has been the CEO since incorporation. | Founder | - |
Former positions of Fredrick D. Ashbury
| Companies | Position | End |
|---|---|---|
| York University | Corporate Officer/Principal | - |
| University of Manitoba | Corporate Officer/Principal | - |
| University of Toronto | Corporate Officer/Principal | - |
| McGill University | Corporate Officer/Principal | - |
OpTx Corp.
 OpTx Corp. Packaged SoftwareTechnology Services Part of Siemens AG, OpTx Corp. is a company that provides oncology-specific software and services providers. The company is based in Englewood, CO. OpTx was acquired by Varian Medical Systems, Inc., part of Siemens AG from April 15, 2021 on March 29, 2004 for $18 million. The company was founded by Gerald Hogue. | Corporate Officer/Principal | - |
Training of Fredrick D. Ashbury
| Queen's University | Graduate Degree |
| University of Toronto | Undergraduate Degree |
| The University of York | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
OpTx Corp.
OpTx Corp. Packaged SoftwareTechnology Services Part of Siemens AG, OpTx Corp. is a company that provides oncology-specific software and services providers. The company is based in Englewood, CO. OpTx was acquired by Varian Medical Systems, Inc., part of Siemens AG from April 15, 2021 on March 29, 2004 for $18 million. The company was founded by Gerald Hogue. | Technology Services |
BridgeSite Clinical Research, Inc.
 BridgeSite Clinical Research, Inc. Medical/Nursing ServicesHealth Services Bridgesite Clinical Research, Inc. engages in the provision of clinical research services. The company was founded by Thomas J. Baxter and is headquartered in Columbus, OH. | Health Services |
Viviphi Ltd.
Viviphi Ltd. Packaged SoftwareTechnology Services Viviphi Ltd., also known as VieCure, is an artificial intelligence platform that has developed a proprietary informatics software platform in conjunction with a clinical inference engine and point-of-care decision support system in oncology. The company is based in Denver, CO. The platform combines the latest in clinical knowledge with patient data to assist clinicians in generating personalized treatment plans and better managing a patient’s treatment throughout diagnosis, cancer therapy, and ongoing follow-up care. The company was founded by Fredrick D. Ashbury, Gerald Hogue. Gerald Hogue has been the CEO since incorporation. | Technology Services |
- Stock Market
- Insiders
- Fredrick D. Ashbury
